-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GupdNQH5kPU/saEDHAzoBLNjHVGqmzdVKjn/Y/zntU/W1E6Cc4fsgbq2GNGyC9Tn gpCp5MIm7ocgG7kbvJeU8A== 0000903423-09-000178.txt : 20090227 0000903423-09-000178.hdr.sgml : 20090227 20090227185626 ACCESSION NUMBER: 0000903423-09-000178 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090225 FILED AS OF DATE: 20090227 DATE AS OF CHANGE: 20090227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BONDERMAN DAVID CENTRAL INDEX KEY: 0000860866 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52082 FILM NUMBER: 09644947 BUSINESS ADDRESS: BUSINESS PHONE: 8178714040 MAIL ADDRESS: STREET 1: C/O COSTAR GROUP INC STREET 2: 7475 WISCONSIN AVENUE #600 CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIDYNE INC CENTRAL INDEX KEY: 0001180145 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 841568247 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1450 INFINITE DRIVE CITY: LOUISVILLE STATE: CO ZIP: 80027 BUSINESS PHONE: 303-665-3450 MAIL ADDRESS: STREET 1: 1450 INFINITE DRIVE CITY: LOUISVILLE STATE: CO ZIP: 80027 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tarrant Advisors, Inc CENTRAL INDEX KEY: 0001339181 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52082 FILM NUMBER: 09644949 BUSINESS ADDRESS: STREET 1: 301 COMMERCE STREET, SUITE 3300 CITY: FORT WORTH STATE: TX ZIP: 76102 BUSINESS PHONE: 817 871 4014 MAIL ADDRESS: STREET 1: 301 COMMERCE STREET, SUITE 3300 CITY: FORT WORTH STATE: TX ZIP: 76102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COULTER JAMES G CENTRAL INDEX KEY: 0001099776 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52082 FILM NUMBER: 09644948 BUSINESS ADDRESS: STREET 1: 345 CALIFORNIA SHEET STREET 2: SUITE 3300 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 4157431500 MAIL ADDRESS: STREET 1: 345 CALIFORNIA STREET STREET 2: SUITE 3300 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 4 1 tarrant-replidynef4_0227ex.xml X0303 4 2009-02-25 1 0001180145 REPLIDYNE INC CSII 0001339181 Tarrant Advisors, Inc C/O TPG GROWTH, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102 0 0 0 1 Former 10% Owner (1) (2) 0000860866 BONDERMAN DAVID 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102 0 0 0 1 Former 10% Owner (1) (2) 0001099776 COULTER JAMES G 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102 0 0 0 1 Former 10% Owner (1) (2) (1) David Bonderman and James G. Coulter are directors, officers and sole shareholders of Tarrant Capital Advisors, Inc., which is the sole shareholder of Tarrant Advisors, Inc. ("Tarrant Advisors" and, together with Messrs. Bonderman and Coulter, the "Reporting Persons"), which is the general partner of TPG Ventures Professionals, LP, which in turn is the general partner of TPG Ventures Partners, LP, which is the managing member of TPG Ventures Holdings, LLC, which is the sole member of each of TPG Ventures Advisors, LLC and TPG Biotechnology Advisors, LLC. TPG Ventures Advisors, LLC is the general partner of TPG Ventures GenPar, LP, which is the general partner of TPG Ventures, LP ("TPG Ventures"). TPG Biotech Advisors, LLC is the general partner of TPG Biotechnology GenPar, LP, which is the general partner of TPG Biotechnology Partners, LP ("TPG Biotech" and together with TPG Ventures, the "TPG Funds"). The TPG Funds directly hold previously reported shares of common stock ("Shares") of the Issuer. Because of the Reporting Persons' relationships to the TPG Funds, they may be deemed to beneficially own such Shares to the extent of the greater of their respective pecuniary interests in the profits or capital accounts of the TPG Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934 (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any Shares in excess of such amounts. (2) Following the merger of Cardiovascular Systems, Inc. into the Issuer effective 2/25/09, the TPG Funds no longer hold over 10% of the Shares and the Issuer's name changed to Cardiovascular Systems, Inc. (3) The Reporting Persons are jointly filing this Form 4 under Exchange Act Rule 16a-3(j). (4) Mr. Bode is signing on behalf of Messrs. Bonderman and Coulter pursuant to previously filed authorizations. /s/ Clive D. Bode, Vice President, Tarrant Advisors, Inc. (3) 2009-02-27 /s/ Clive D. Bode, on behalf of David Bonderman (3) (4) 2009-02-27 /s/ Clive D. Bode, on behalf of James G. Coulter (3) (4) 2009-02-27 -----END PRIVACY-ENHANCED MESSAGE-----